共 50 条
- [1] Solvation modeling for rational drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U464 - U465
- [2] Free energy calculations in rational drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U896 - U896
- [3] Data mining of crystallographic databases as an aid to drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U302 - U302
- [4] Crystallographic databases and knowledge bases in materials design [J]. IMPLICATIONS OF MOLECULAR AND MATERIALS STRUCTURE FOR NEW TECHNOLOGIES, 1999, 360 : 291 - 302
- [5] Knowledge-based potentials in drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U36 - U36
- [6] Use of genomic information in drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U390 - U390
- [7] AEI: Knowledge-based potentials in drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U518 - U518
- [8] Structure of Casein Kinase 1A as a Tool in Rational Drug Design. [J]. PROTEIN SCIENCE, 2018, 27 : 199 - 200
- [9] Integrated pharmacokinetic-pharmacodynamic modeling as a basis for rational drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U965 - U965
- [10] Finding the needle in a haystack: Synergy between rational and combinatorial drug design. [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U526 - U526